IGC Pharma, Inc. (IGC)
0.34
+0.04
(+14.09%)
USD |
NYAM |
Dec 10, 13:04
IGC Pharma Market Cap: 31.58M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Esperion Therapeutics, Inc. | 893.75M |
| Theravance Biopharma, Inc. | 884.74M |
| NRX Pharmaceuticals, Inc. | 61.67M |
| CEL-SCI Corp. | 19.48M |
| AIM ImmunoTech, Inc. | 1.116M |
Market Cap Related Metrics
| PS Ratio | 25.52 |
| Price to Book Value | 3.902 |
| Price | 0.34 |
| Earnings Yield | -22.88% |